Saturday, July 21, 2018

ADAMCAPITAL Gestao de Recursos Ltda. Sells 55,267 Shares of Biogen Inc (BIIB)

ADAMCAPITAL Gestao de Recursos Ltda. lowered its holdings in Biogen Inc (NASDAQ:BIIB) by 30.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 125,856 shares of the biotechnology company’s stock after selling 55,267 shares during the quarter. Biogen comprises approximately 1.8% of ADAMCAPITAL Gestao de Recursos Ltda.’s portfolio, making the stock its 16th largest holding. ADAMCAPITAL Gestao de Recursos Ltda.’s holdings in Biogen were worth $36,528,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Amalgamated Bank increased its position in shares of Biogen by 5.9% in the second quarter. Amalgamated Bank now owns 32,613 shares of the biotechnology company’s stock worth $9,466,000 after acquiring an additional 1,828 shares in the last quarter. World Asset Management Inc increased its position in shares of Biogen by 2.0% in the second quarter. World Asset Management Inc now owns 14,471 shares of the biotechnology company’s stock worth $4,200,000 after acquiring an additional 278 shares in the last quarter. Prospera Financial Services Inc increased its position in shares of Biogen by 47.9% in the second quarter. Prospera Financial Services Inc now owns 1,652 shares of the biotechnology company’s stock worth $483,000 after acquiring an additional 535 shares in the last quarter. Bedrijfstakpensioenfonds Voor DE Media PNO increased its position in shares of Biogen by 25.0% in the second quarter. Bedrijfstakpensioenfonds Voor DE Media PNO now owns 40,000 shares of the biotechnology company’s stock worth $11,610,000 after acquiring an additional 8,000 shares in the last quarter. Finally, Pendal Group Ltd increased its position in shares of Biogen by 5.1% in the second quarter. Pendal Group Ltd now owns 46,799 shares of the biotechnology company’s stock worth $13,583,000 after acquiring an additional 2,273 shares in the last quarter. 87.43% of the stock is owned by institutional investors.

Get Biogen alerts:

In related news, Director Alexander J. Denner acquired 48,000 shares of Biogen stock in a transaction on Wednesday, April 25th. The shares were purchased at an average cost of $269.91 per share, for a total transaction of $12,955,680.00. Following the purchase, the director now directly owns 10,029 shares of the company’s stock, valued at approximately $2,706,927.39. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.29% of the company’s stock.

NASDAQ BIIB traded up $0.17 during trading hours on Thursday, reaching $358.68. 45,163 shares of the company traded hands, compared to its average volume of 2,001,924. Biogen Inc has a 12 month low of $249.17 and a 12 month high of $370.57. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.23 and a quick ratio of 2.95. The company has a market capitalization of $74.90 billion, a price-to-earnings ratio of 16.44, a price-to-earnings-growth ratio of 1.72 and a beta of 0.80.

Biogen (NASDAQ:BIIB) last posted its quarterly earnings data on Tuesday, April 24th. The biotechnology company reported $6.05 EPS for the quarter, beating the Zacks’ consensus estimate of $5.93 by $0.12. Biogen had a net margin of 23.54% and a return on equity of 37.64%. The firm had revenue of $3.13 billion for the quarter, compared to the consensus estimate of $3.15 billion. During the same period in the prior year, the firm posted $5.20 EPS. The firm’s revenue was up 11.4% compared to the same quarter last year. analysts anticipate that Biogen Inc will post 23.97 EPS for the current year.

BIIB has been the subject of several recent research reports. Barclays lowered shares of Biogen from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $395.00 to $295.00 in a research report on Thursday, April 5th. Canaccord Genuity set a $350.00 price objective on shares of Biogen and gave the stock a “hold” rating in a research report on Monday, April 9th. Sanford C. Bernstein set a $318.00 price target on shares of Biogen and gave the company a “buy” rating in a report on Tuesday, April 10th. Mizuho set a $433.00 price target on shares of Biogen and gave the company a “buy” rating in a report on Wednesday, April 11th. Finally, Credit Suisse Group set a $384.00 price target on shares of Biogen and gave the company a “buy” rating in a report on Tuesday, April 17th. Ten research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $360.79.

Biogen Profile

Biogen Inc discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy.

See Also: What does RSI mean?

Want to see what other hedge funds are holding BIIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Biogen Inc (NASDAQ:BIIB).

Institutional Ownership by Quarter for Biogen (NASDAQ:BIIB)

Friday, July 20, 2018

iShares Core 1-5 Year USD Bond ETF (ISTB) Position Cut by Northstar Investment Advisors LLC

Northstar Investment Advisors LLC trimmed its position in iShares Core 1-5 Year USD Bond ETF (NASDAQ:ISTB) by 20.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,671 shares of the company’s stock after selling 14,909 shares during the quarter. Northstar Investment Advisors LLC owned 0.14% of iShares Core 1-5 Year USD Bond ETF worth $5,607,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. BDO Wealth Advisors LLC bought a new position in iShares Core 1-5 Year USD Bond ETF in the first quarter valued at approximately $111,000. Peddock Capital Advisors LLC bought a new stake in shares of iShares Core 1-5 Year USD Bond ETF during the first quarter worth $112,000. Private Capital Group LLC grew its stake in shares of iShares Core 1-5 Year USD Bond ETF by 313.7% during the first quarter. Private Capital Group LLC now owns 3,512 shares of the company’s stock worth $173,000 after buying an additional 2,663 shares during the last quarter. First Allied Advisory Services Inc. grew its stake in shares of iShares Core 1-5 Year USD Bond ETF by 86.4% during the first quarter. First Allied Advisory Services Inc. now owns 4,629 shares of the company’s stock worth $230,000 after buying an additional 2,146 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in shares of iShares Core 1-5 Year USD Bond ETF during the first quarter worth $229,000.

Get iShares Core 1-5 Year USD Bond ETF alerts:

Shares of iShares Core 1-5 Year USD Bond ETF remained flat at $$49.01 during midday trading on Thursday, according to Marketbeat Ratings. 70,891 shares of the company’s stock were exchanged, compared to its average volume of 285,043. iShares Core 1-5 Year USD Bond ETF has a 12-month low of $48.89 and a 12-month high of $50.47.

The business also recently announced a monthly dividend, which was paid on Monday, July 9th. Shareholders of record on Tuesday, July 3rd were paid a dividend of $0.1011 per share. The ex-dividend date of this dividend was Monday, July 2nd. This represents a $1.21 dividend on an annualized basis and a dividend yield of 2.48%.

Featured Story: What is the Book Value of a Share?

Institutional Ownership by Quarter for iShares Core 1-5 Year USD Bond ETF (NASDAQ:ISTB)

Monday, July 16, 2018

Top 10 Tech Stocks To Buy For 2019

tags:CSGS,PRGS,JBL,UMC,AMGN,MAMS,SAIC,EBIX,CSLT,FLOW, Move over Warren Buffett! Amazon CEO Jeff Bezos is now the second richest person on Earth.

The latest tally by Bloomberg's Billionaires Index shows Bezos is now worth about $75.6 billion. Another ranking compiled by Forbes has Bezos' value at "just" $75.2 billion.

He added $1.5 billion to his net worth after Amazon (AMZN, Tech30) gained $9 billion in market value during trading hours Wednesday.

The company received a generous stock bump after a Barclay's (AGRPY) analyst declared Amazon will "likely to be one of the first trillion-dollar market cap companies." Its shares hit a record high shortly after.

Amazon's stock has been on fire lately -- it's grown more than 16% over the last year. Investors were pleased with the company's decision, announced yesterday, to buy Souq, an e-commerce giant in the Middle East.

Amazon isn't Bezos's only venture. He also owns space exploration company Blue Origin. Its goal is to eventually take people on "space tourism" trips and to deliver satellites into orbit for corporate climates. So far, the company has only conducted test flights.

Top 10 Tech Stocks To Buy For 2019: CSG Systems International Inc.(CSGS)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CSG International (CSGS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CSG International (NASDAQ:CSGS) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Saturday.

Top 10 Tech Stocks To Buy For 2019: Progress Software Corporation(PRGS)

Advisors' Opinion:
  • [By Shane Hupp]

    Smith Asset Management Group LP cut its holdings in shares of Progress Software (NASDAQ:PRGS) by 45.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,653 shares of the software maker’s stock after selling 52,380 shares during the period. Smith Asset Management Group LP owned 0.14% of Progress Software worth $2,371,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Progress Software (NASDAQ:PRGS) posted its quarterly earnings results on Wednesday. The software maker reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.07, RTT News reports. Progress Software had a net margin of 13.86% and a return on equity of 25.03%. The firm had revenue of $96.10 million for the quarter, compared to analyst estimates of $95.03 million. During the same period in the previous year, the business posted $0.42 earnings per share. Progress Software’s quarterly revenue was up 3.1% on a year-over-year basis. Progress Software updated its Q3 guidance to $0.56-$0.58 EPS and its FY18 guidance to $2.45-$2.50 EPS.

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it's a taboo investment that is creating millionaires all across North America. Tap into the "green rush," and prepare to become a "Marijuana millionaire." Learn how to get started right here.

    The Top Stock Market Stories for Wednesday U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. "Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag," Trump tweeted Tuesday. "I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!" Earlier this month,�Microsoft Corp.�(Nasdaq:�MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential for�Microsoft stock. Here's why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from "pre-approved advisers." According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone. Four Stocks to Watch Today: ORCL, FB, GOOGL, BA Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

Top 10 Tech Stocks To Buy For 2019: Jabil Circuit Inc.(JBL)

Advisors' Opinion:
  • [By Motley Fool Staff]

    Jabil (NYSE:JBL)Q3 2018 Earnings Conference CallJune 14, 2018, 4:30 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Peter Graham]

    Nevertheless, a long term performance chart shows Sanmina Corp previously being an outperformer, but now falling off while�potential large cap peer Flextronics International Ltd (NASDAQ: FLEX) has given a steady performance over the last two years and small cap�Celestica Inc (NYSE: CLS) and mid cap�Jabil Circuit, Inc (NYSE: JBL) have similar unaspiring charts:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, and�mid cap Flextronics International being bigger winners (albeit FLEX has steadily risen for two years while SANM has already peaked) compared with the moderately positive performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

Top 10 Tech Stocks To Buy For 2019: United Microelectronics Corporation(UMC)

Advisors' Opinion:
  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get UMC alerts: UMC �� United Microelectronics Corporation: UMC Shareholders Elect 14th Term of Directors at Annual Shareholders Meeting (twst.com) UPDATE: Bernstein Upgrades United Microelectronics (UMC) to Market Perform (streetinsider.com) UMC��s new burn center fills three-decade need in New Orleans (neworleanscitybusiness.com) Community breakfast at Sparta UMC is open to all (mlive.com) Shopper News blog: Beaver Ridge UMC youth �� ‘we’re there to help’ (knoxnews.com)

    A number of brokerages recently commented on UMC. Sanford C. Bernstein upgraded shares of UMC from an “underperform” rating to a “market perform” rating and lifted their target price for the stock from $2.10 to $2.60 in a research report on Sunday. ValuEngine cut shares of UMC from a “buy” rating to a “hold” rating in a research report on Thursday, April 26th. Six investment analysts have rated the stock with a sell rating, four have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. UMC presently has an average rating of “Hold” and a consensus price target of $2.60.

  • [By Nicholas Rossolillo]

    Speaking of trade wars, the one looming between the world's two largest economies, the U.S. and China, has been under the microscope. To kick off July, a court in China suspended sales of 26 products from semiconductor manufacturer Micron Technology�(NASDAQ:MU). The Idaho-based maker of memory chips has been embroiled in a patent infringement dispute with Taiwan-based United Microelectronics (NYSE: UMC), and this latest turn is a point in favor of the latter.

Top 10 Tech Stocks To Buy For 2019: Amgen Inc.(AMGN)

Advisors' Opinion:
  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest fall slightly to 10.61 million shares from the previous level of 10.72 million. Shares were last seen at $184.59, in a 52-week trading range of $163.31 to $201.23.

  • [By Ethan Ryder]

    Wayne Hummer Investments L.L.C. trimmed its position in shares of Amgen (NASDAQ:AMGN) by 11.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,311 shares of the medical research company’s stock after selling 303 shares during the period. Wayne Hummer Investments L.L.C.’s holdings in Amgen were worth $394,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Private Capital Group LLC boosted its stake in Amgen, Inc. (NASDAQ:AMGN) by 1,703.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,362 shares of the medical research company’s stock after purchasing an additional 2,231 shares during the period. Private Capital Group LLC’s holdings in Amgen were worth $403,000 at the end of the most recent reporting period.

Top 10 Tech Stocks To Buy For 2019: MAM Software Group, Inc.(MAMS)

Advisors' Opinion:
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MAM Software Group (MAMS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Tech Stocks To Buy For 2019: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION(SAIC)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Science Applications International (SAIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rich Smith]

    Investors in Science Applications International Corporation (NYSE:SAIC) had a bad week last week: Its stock plunged 8% in a single day after it reported earnings -- and ended the week even lower. SAIC shares are clawing back some losses this week -- but do they deserve to?

  • [By Rich Smith]

    Let's start with the story that sparked the rally. Last night, Reuters cited three sources "familiar with the matter" saying that Engility "is exploring a sale" -- perhaps to CACI International (NYSE:CACI) or Science Applications International Corp (NYSE:SAIC), two peer defense contractors that are both three to four times larger than Engility.

  • [By Lou Whiteman]

    The Marine Corps has selected BAE Systems (NASDAQOTH:BAESY) to manufacture its next-generation amphibious combat vehicle, dealing a major setback to the diversification plans of Science Applications International (NYSE:SAIC).

  • [By Garrett Baldwin]

    Today, Bill offers our readers a few of his favorites as Trump meets with Kim Jong Un.�Here's how to cash in regardless of how this summit turns out in the long run.

    The Top Stock Market Stories for Tuesday Last night, President Trump met North Korean leader Kim Jong Un in Singapore. This was the first meeting between a sitting American president and a North Korean leader. Following the agreement, analysts noted that the document signed by both parties included no concrete details for achieving denuclearization on the Korean Peninsula. Trump responded to criticism by saying he is fully confident that the Korean dictatorship will follow through. A U.S. district court will rule on whether to approve an $85 billion merger between AT&T Inc. (NYSE: T) and Time Warner Inc. (NYSE: TWX). The decision comes after about six weeks of debate in a courtroom. The ruling will likely have a significant impact on the proposed bid by The Walt Disney Co. (NYSE: DIS) for media giant Twenty-First Century Fox Inc.�(NYSE: FOXA). The Fed Open Market Committee kicks off its June meeting today. The U.S. central bank is expected to raise interest rates for the second time in 2018. On Wednesday, U.S. Federal Reserve Chair Jerome Powell will likely announce a hike of 0.25% to the benchmark rate to 2%. This would also mark the seventh hike since December 2015. Markets will be looking for clues during Powell's conference to determine how many additional times the Fed plans to raise interest rates during the final six months of the year. Three Stocks to Watch Today: RH, TSLA, GE Restoration Hardware Holdings Inc. (NYSE: RH) stock popped more than 20% in pre-market hours after the company reported very strong profits for the quarter. The retailer reported earnings per share of $1.33, well above the $1.02 anticipated by analysts. The company also reported a strong second-quarter outlook, news that reduced concerns about it falling short of revenue expectations. Tesla Inc. (Nasdaq: TS

Top 10 Tech Stocks To Buy For 2019: Ebix, Inc.(EBIX)

Advisors' Opinion:
  • [By Shane Hupp]

    Shares of Ebix Inc (NASDAQ:EBIX) have been assigned a consensus recommendation of “Buy” from the six ratings firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $100.00.

  • [By Ethan Ryder]

    Ebix (NASDAQ:EBIX) issued its earnings results on Wednesday. The technology company reported $0.83 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.01), MarketWatch Earnings reports. The business had revenue of $108.23 million for the quarter, compared to analysts’ expectations of $106.81 million. Ebix had a return on equity of 20.67% and a net margin of 27.65%. Ebix’s revenue for the quarter was up 36.8% on a year-over-year basis.

  • [By Shane Hupp]

    ARS Investment Partners LLC boosted its position in shares of Ebix Inc (NASDAQ:EBIX) by 62.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 92,910 shares of the technology company’s stock after acquiring an additional 35,681 shares during the quarter. ARS Investment Partners LLC owned 0.30% of Ebix worth $6,922,000 at the end of the most recent quarter.

Top 10 Tech Stocks To Buy For 2019: Castlight Health, inc.(CSLT)

Advisors' Opinion:
  • [By Max Byerly]

    Zendesk (NYSE: ZEN) and Castlight Health (NYSE:CSLT) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Castlight Health (CSLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Tech Stocks To Buy For 2019: SPX FLOW, Inc.(FLOW)

Advisors' Opinion:
  • [By Max Byerly]

    Get a free copy of the Zacks research report on Flow International (FLOW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Dynamic Technology Lab Private Ltd increased its position in shares of SPX Flow Inc (NYSE:FLOW) by 38.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,824 shares of the industrial products company’s stock after buying an additional 2,738 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in SPX Flow were worth $483,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spx Flow (FLOW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com